Filing Flows › Apyx Medical (APYX) › Q2 2026 › vs Q1 2026
Apyx Medical (APYX) Q2 2026 vs Q1 2026 (quarter over quarter)
Apyx Medical's revenue rose $1.4M (+11%) from $12.5M in Q1 2026 to $13.9M in Q2 2026.
Apyx Medical, Q2 2026: revenue $13.9M (+22% year over year), operating margin -13.0%, net loss $3.1M, operating cash flow −$3.5M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $13.9M | $12.5M | $1.4M | +11% |
| Net loss | $3.1M | $2.1M | $929K | +43% |
| Costs & expenses | $17.0M | $14.6M | $2.3M | +16% |
| Operating costs | $15.7M | $13.4M | $2.3M | +17% |
| Interest & other, net | $1.1M | $1.1M | $53K | +5% |
| Income tax | $124K | $143K | −$19K | -13% |
| Cost of revenue | $5.0M | $4.6M | $449K | +10% |
| Research & development | $793K | $765K | $28K | +4% |
| SG&A | $5.3M | $3.6M | $1.7M | +48% |
| Other operating costs | $4.6M | $4.5M | $103K | +2% |
| Operating cash sources | $4.8M | $1.1M | $3.7M | +338% |
| Depreciation & amortization | $196K | $202K | −$6K | -3% |
| Share-based compensation | $1.1M | $312K | $762K | +244% |
| Cash used in operations | $3.5M | $572K | $2.9M | +510% |
| Net loss absorbed | $3.1M | $2.1M | $929K | +43% |
| Working capital & other | $1.7M | −$1.1M | $2.7M | — |
Questions
How much did Apyx Medical's revenue grow quarter over quarter in Q2 2026?
Apyx Medical's revenue rose $1.4M (+11%) from $12.5M in Q1 2026 to $13.9M in Q2 2026.